Received Mar 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | — | IM |
Patient was contacted by the pharmacy to inform her that her second dose was sooner than the recommendation by the CDC. She was informed that because of an early dose, she is more likely to experience side effects or adverse events. At this time, patient stated that she did experience side effects that she didn?t have on dose one. She stated that she developed a rash on her arm. It was larger than just at the injection site. She stated that it did not hurt or itch and so she did not seek medical attention. It resolved within a couple of days on its own.